Related Experiment Video
Updated: Feb 14, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Coronary Flow Reserve in Non-Infarcted Myocardium Predicts Long-Term Clinical Outcomes in Patients Undergoing
Rongchao Cheng1, Xiaoming Zhu2, Yunling Li1
1Department of Cardiology, the Forth Affiliated Hospital of Harbin Medical University, Harbin, China.
Insights
Coronary flow reserve (CFR) in non-infarcted heart muscle predicts future major adverse cardiac events (MACEs) after acute myocardial infarction (AMI) and percutaneous coronary intervention (PCI). Lower CFR indicates a higher risk of MACEs within 12 months.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Myocardial Perfusion Assessment
Background:
- Coronary flow reserve (CFR) is a key indicator of myocardial perfusion.
- Assessing CFR in non-infarcted areas may offer prognostic value in acute myocardial infarction (AMI) patients.
Purpose of the Study:
- To evaluate the association between non-infarcted myocardial CFR and the incidence of major adverse cardiac events (MACEs).
- To determine if CFR predicts 12-month MACEs in patients with AMI undergoing percutaneous coronary intervention (PCI).
Main Methods:
- 100 patients with AMI post-PCI were categorized into MACE and non-MACE groups based on 12-month outcomes.
- Left ventricular function and CFR were assessed using echocardiography and myocardial contrast echocardiography one week post-PCI.
- Peak cardiac troponin I levels were measured.
Main Results:
- Patients experiencing MACEs had significantly lower CFR compared to the non-MACE group (2.41 vs. 2.77, p<0.001).
- Multivariable analysis identified non-infarcted myocardial CFR as an independent predictor of 12-month MACEs (HR: 0.093, 95% CI: 0.020-0.426, p=0.002).
Conclusions:
- CFR in the non-infarcted myocardium serves as a valuable marker for predicting 12-month MACEs.
- This finding is significant for patients with AMI undergoing primary PCI.
Purpose:
Coronary flow reserve (CFR) is recognized as an indicator of myocardial perfusion. The aim of this study was to assess the relationship between CFR in the non-infarcted myocardium and the incidence of major adverse cardiac events (MACEs).
Materials And Methods:
100 consecutive patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) were enrolled in the present study, and divided into MACE and non-MACE groups according to the incidence of 12-month MACEs. Left ventricular function and CFR were analyzed using two-dimensional echocardiography and myocardial contrast echocardiography at one week after PCI. Cardiac troponin I levels were assayed to estimate peak concentrations thereof.
Results:
The MACE group was associated with lower CFR, compared to the non-MACE group (2.41 vs. 2.77, p<0.001). In the multivariable model, CFR in the non-infarcted myocardium was an independent predictor of 12-month MACE (hazard ratio: 0.093, 95% confidence interval: 0.020-0.426, p=0.002) after adjustment for baseline demographic and clinical characteristics.
Conclusion:
CFR in the non-infarcted myocardium is a useful marker for predicting 12-month MACEs in patients with AMI undergoing primary PCI.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Predicting Reaction Outcomes
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology

